Lannett Makes Deal For Respirent’s Flovent Diskus Rival

Also Extends Distribution Term for Advair Rival To 12 Years

 
• By Akriti Seth
  
Lungs
Lannett continues to expand its portfolio for inhalation medications • Source: Shutterstock

More from Deals

More from Business